Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.
Open Access
- 1 August 1985
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 48 (8) , 842-843
- https://doi.org/10.1136/jnnp.48.8.842
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Dementia in Patients with Parkinson’s Disease: Review of Biochemical DataPublished by Springer Nature ,1985
- A subcortico-cortical cholinergic system is affected in Parkinson's diseaseBrain Research, 1983
- Somatostatin and dementia in Parkinson's diseaseBrain Research, 1983
- Co-localization of vasoactive intestinal peptide (VIP) and enkephalins in chromaffin cells of the adrenal gland of amphibia. Stimulation of corticosteroid production by VIPLife Sciences, 1983
- Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementiaBrain Research, 1982
- Reduced corticol choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptideBrain Research, 1980
- Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's diseaseBrain Research, 1979
- Dementia in Parkinson diseaseNeurology, 1979
- NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIAThe Lancet, 1977